Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standardof care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+),well-differentiated gastro-enteropancreatic
Greeno, E. W. (PI)
7/29/24 → 1/31/34
Project: Research project
-
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of OralTinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor-Refracto
Greeno, E. W. (PI)
TRANSTHERA SCIENCES (NANJING), INC.
2/26/24 → 2/28/34
Project: Research project
-
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K. (PI), Geller, M. A. (CoI), Greeno, E. W. (CoI), Kratzke, R. A. (CoI), Ondrey, F. G. (CoI), Teoh, D. G. (CoI) & Yee, D. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
-
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel in Patients with Metastatic PancreaticDuctal Adenocarcinoma (RELIANT)
Greeno, E. W. (PI)
CORCEPT THERAPEUTICS INCORPORATED
7/27/20 → 7/31/25
Project: Research project
-
An open-label, randomised, multicentre, phase III study of irinotecanliposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine insubjects who have not previously received chemotherapy for metastatic adenocarcinom
Greeno, E. W. (PI)
3/24/20 → 3/31/25
Project: Research project
-
Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review
Troester, A., Parikh, R., Southwell, B., Ester, E., Sultan, S., Greeno, E., Arsoniadis, E., Church, T. R., Wilt, T., Butler, M. & Goffredo, P., Feb 1 2025, In: Journal of the National Cancer Institute. 117, 2, p. 240-252 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity
Borazanci, E., Saluja, A., Gockerman, J., Velagapudi, M., Korn, R., Von Hoff, D. & Greeno, E., Feb 2024, In: Oncologist. 29, 2, p. 132-141 10 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A phase I, dose escalation, single dose trial of oral attenuated salmonella typhimurium containing human IL-2 in patients with metastatic gastrointestinal cancers
Gniadek, T. J., Augustin, L., Schottel, J., Leonard, A. S., Saltzman, D., Greeno, E. & Batist, G., Sep 1 2020, In: Journal of Immunotherapy. 43, 7, p. 217-221 5 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations -
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Hurwitz, H., Van Cutsem, E., Bendell, J., Hidalgo, M., Li, C. P., Salvo, M. G., Macarulla, T., Sahai, V., Sama, A., Greeno, E. W., Yu, K. H., Verslype, C., Dawkins, F., Walker, C., Clark, J. & O’Reilly, E. M., Aug 1 2018, In: Investigational New Drugs. 36, 4, p. 683-695 13 p.Research output: Contribution to journal › Article › peer-review
Open Access85 Scopus citations -
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
Goldstein, D., Von Hoff, D. D., Moore, M., Greeno, E., Tortora, G., Ramanathan, R. K., Macarulla, T., Liu, H., Pilot, R., Ferrara, S. & Lu, B., Jan 2016, In: European Journal of Cancer. 52, p. 85-91 7 p.Research output: Contribution to journal › Article › peer-review
Open Access36 Scopus citations